‘Fear, uncertain, tired…...’ psychological distress among pulmonary hypertension patients: a qualitative interview study
-
Published:2024-02-05
Issue:1
Volume:24
Page:
-
ISSN:1471-244X
-
Container-title:BMC Psychiatry
-
language:en
-
Short-container-title:BMC Psychiatry
Author:
Zhang Juxia,Zhang Yiyin,Yin Yuhuan,Feng Yuping,Zhang Rong,Meng Hongyan,Wang Jing
Abstract
Abstract
Background
Patient-centered health care for patients with pulmonary hypertension (PH) is important and requires an understanding of patient experiences. However, there is a lack of approaches to examine what's the effects and how the disease impact patients’ psychological well-beings.
Methods
We conducted qualitative interviews with PH patient representatives to understand patient psychological experiences and inform patient-centered research and care. Participants were chosen from a tertiary hospital located in northwest China. 20 patients with PH who be treated at the hospital (13 participants were women, aged 18-74 years) were strategically selected and individually interviewed. We used qualitative analysis to identify themes relating to existential psychological distress that would clarify the nature of such concerns.
Results
We found that patients experience tremendous psychological distress throughout the treatment process. Four categories that describe patients' psychological experiences emerged: burden of PH treatment, fear and uncertainty about the disease, frustration in social and family role, and lack of recognition of the condition.
Conclusions
Existential concerns are salient in PH and involve the experience of loss and disruptions to the sense of self and relationships. Healthcare practitioners must work more in collaboration to detect patients' need for support and to develop the patient's own skills to manage daily life. The PH teams should tailor interventions to provide emotional, informational and instrumental support and guidance to patients.
Funder
China Medical Education Association
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Medicine The Lancet Respiratory. Pulmonary hypertension: still a rare disease? Lancet Respir Med. 2016;4(4):241. 2. Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S; ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2023;61(1):2200879. 3. Rosenkranz S, Delcroix M, Giannakoulas G, Hoeper MM, Kovacs G, Humbert M. The “Ten Commandments” of the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2023;44(10):792–3. 4. Gelzinis TA. Pulmonary Hypertension in 2021: Part I-Definition, Classification, Pathophysiology, and Presentation. J Cardiothorac Vasc Anesth. 2022;36(6):1552–64. 5. Van Nuffel S, Quatredeniers M, Pirkl A, Zakel J, Le Caer JP, Elie N, Vanbellingen QP, Dumas SJ, Nakhleh MK, Ghigna MR, Fadel E, Humbert M, Chaurand P, Touboul D, Cohen-Kaminsky S, Brunelle A. Multimodal Imaging Mass Spectrometry to Identify Markers of Pulmonary Arterial Hypertension in Human Lung Tissue Using MALDI-ToF, ToF-SIMS, and Hybrid SIMS. Anal Chem. 2020;92(17):12079–87.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|